EFFECT OF THE AROMATASE INHIBITOR, 4-HYDROXYANDROSTENEDIONE, ON THE ENDOTOXIN-INDUCED CHANGES IN STEROID-HORMONES IN MALE-RATS

被引:15
作者
CHRISTEFF, N
AUCLAIR, MC
DEHENNIN, L
THOBIE, N
BENASSAYAG, C
CARLI, A
NUNEZ, EA
机构
[1] CNRS,INSERM,U224,16 RUE HENRI HUCHARD,F-75018 PARIS,FRANCE
[2] INSERM,U228,F-75006 PARIS,FRANCE
[3] HOP COCHIN,SERV REANIMAT POLYVALENTE,F-75674 PARIS 14,FRANCE
[4] FDN RECH HORMONOL,F-94268 FRESNES,FRANCE
关键词
D O I
10.1016/0024-3205(92)90265-Q
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The increase in circulating estrogen concentrations that follows injection of Escherischia coli endotoxin (Endo) may be due to increased aromatase activity. We have therefore analysed the effect of the aromatase inhibitor, 4 hydroxyandrostenedione (4OHA) on the steroid hormone response of male rats, particularly the dramatic increase in estrogens and decrease in androgens, induced by Endo. The concentrations of corticosterone (B), progesterone (P4), 17-alpha-hydroxyprogesterone (17-alpha-OHP4), androstenedione (DELTA-4), testosterone (T), estrone (E1) and estradiol (E2) were determined 2 hours after injection of increasing doses of 4OHA with and without Endo. The increase in serum estrogen concentrations and drop in serum androgen levels in response to Endo were blocked by a single dose of 4OHA. The effect of 4OHA appeared to be dose dependent. Low doses (30 mg/kg and 50 mg/kg) induced significant changes in the estrogen and androgen responses, but the high dose (100 mg/kg) blocked all changes in sex steroids induced by Endo. 4OHA did not alter the Endo-induced changes in other steroids.
引用
收藏
页码:1459 / 1468
页数:10
相关论文
共 29 条
[1]  
BAIRD DT, 1969, J ENDOCRINOL, V45, P1135
[2]   EARLY RELEASED LIPID-SOLUBLE CARDIODEPRESSANT FACTOR AND ELEVATED ESTROGENIC SUBSTANCES IN HUMAN SEPTIC SHOCK [J].
BENASSAYAG, C ;
CHRISTEFF, N ;
AUCLAIR, MC ;
VERNIMMEN, C ;
CARLIVIELLE, C ;
NUNEZ, E ;
CARLI, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (04) :288-294
[3]   ABNORMAL INDUCTION OF AROMATASE-ACTIVITY BY DEXAMETHASONE IN FIBROBLASTS FROM A PATIENT WITH CORTISOL RESISTANCE [J].
BERKOVITZ, GD ;
CARTER, KM ;
LEVINE, MA ;
MIGEON, CJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (06) :1608-1611
[4]  
BRODIE AM, 1986, CRC CRIT REV ONCOL, V5, P161
[5]   AROMATASE INHIBITORS AND THEIR POTENTIAL CLINICAL-SIGNIFICANCE [J].
BRODIE, AMH ;
WING, LY ;
GOSS, P ;
DOWSETT, M ;
COOMBES, RC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (5B) :859-865
[6]   AROMATASE INHIBITORS - BASIC AND CLINICAL-STUDIES [J].
BRODIE, AMH ;
COOMBES, RC ;
DOWSETT, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 27 (4-6) :899-903
[7]   INHIBITION OF PERIPHERAL AROMATIZATION BY AROMATASE INHIBITORS, 4-HYDROXY-ANDROSTENE-3,17-DIONE AND 4-ACETOXY-ANDROSTENE-3,17-DIONE [J].
BRODIE, AMH ;
LONGCOPE, C .
ENDOCRINOLOGY, 1980, 106 (01) :19-21
[8]   AROMATASE INHIBITORS AND THE TREATMENT OF BREAST-CANCER [J].
BRODIE, AMH ;
WING, LY ;
GOSS, P ;
DOWSETT, M ;
COOMBES, RC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 24 (01) :91-97
[9]   EFFECT OF AN AROMATASE INHIBITOR, 4-HYDROXY-4-ANDROSTENE-3,17-DIONE, ON ESTROGEN-DEPENDENT PROCESSES IN REPRODUCTION AND BREAST-CANCER [J].
BRODIE, AMH ;
SCHWARZEL, WC ;
SHAIKH, AA ;
BRODIE, HJ .
ENDOCRINOLOGY, 1977, 100 (06) :1684-1695
[10]  
CARLI A, 1981, CIRC SHOCK, V8, P301